Results 261 to 270 of about 114,909 (286)

Carbapenems

2006
openaire   +1 more source

Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

Clinical Microbiology Reviews, 2017
Li Yang Hsu, Anucha Apisarnthanarak, Nuntra Suwantarat   +2 more
exaly  

Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study

Lancet Infectious Diseases, The, 2020
David van Duin, Liang Chen, Blake M Hanson   +2 more
exaly  

The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace

Journal of Infectious Diseases, 2017
Latania K Logan, Robert A Weinstein
exaly  

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Lancet Infectious Diseases, The, 2018
Mical Paul, George L Daikos, Emanuele Durante Mangoni   +2 more
exaly  

Carbapenems

2014
openaire   +1 more source

Carbapenems/immunosuppressants

Reactions Weekly, 2009
openaire   +1 more source

Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China

EBioMedicine, 2017
Rong Zhang, Yi Li, Kang Liao
exaly  

Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii

Drug Resistance Updates, 2012
Nabil Karah, Arnfinn Sundsfjord, Ørjan Samuelsen   +2 more
exaly  

Carbapeneme

Alexander Bott, Marika Busse, Maximilian Waldner   +2 more
openaire   +1 more source